Previous 10 | Next 10 |
Should you buy penny stocks today ? If you like volatility, quick gains, handle high-risk situations and understand trading basics, I say, why not? But the stock market today isn’t like it was even just a year ago. The fact is, millions of new traders have flooded into the market...
Gainers: ImmunoPrecise Antibodies (IPA) +157%.India Globalization Capital (IGC) +74%.NRx Pharmaceuticals (NRXP) +56%.Universe Pharmaceuticals (UPC) +30%.Summit Wireless Technologies (WISA) +28%.Support.com (SPRT) +25%.Agrify Corporation (AGFY) +20%.PainReform (PRFX) +19%.Resources Connec...
Gainers: ImmunoPrecise Antibodies (IPA) +88%, PainReform (PRFX) +48%, NRx Pharmaceuticals (NRXP) +30%, NeuroMetrix (NURO) +27%, Universe Pharmaceuticals (UPC) +18%.Losers: Seres Therapeutics (MCRB) -57%, Jupiter Wellness (JUPW)&...
ImmunoPrecise Antibodies (IPA) announces new results from its TATX-03 PolyTope therapy showing potent pseudovirus neutralizing activity against the SARS-CoV-2 Delta (B.1.617.2) variant.The therapy is a four monoclonal antibody cocktail developed for the potential prevention and...
IPA publishes its scientific paper “Cornering an Ever-Evolving Coronavirus: TATX-03, a Fully Human, Synergistic, Multi-Antibody Cocktail Targeting the SARS-CoV-2 Spike Protein with in vivo Efficacy” on bioRxiv IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or...
San Jose, CA - ( NewMediaWire ) - July 15, 2021 - Logiq, Inc., a global provider of award-winning e-commerce and fintech solutions, leverages SAIBRE, Sonasoft Corp.’s (OTCQB: SSFT) AI bot engine, to uncover new business insights and intelligence. Sonasoft’s AI experts hav...
The Company to host an earnings conference call via webcast on July 28, 2021, after the close of market IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ:IPA) (TSX VENTURE:IPA) a leader in full-service, therapeutic antibody discovery and development, today annou...
IMMUNOPRECISE ANTIBODIES LTD (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) the market leader in full-service therapeutic discovery and development and Eurofins Discovery, the leading provider of products and services to the drug discovery industry and a Eurofins Scientific (...
ImmunoPrecise Antibodies (IPA) jumps 11% premarket after announcing additional results from its in vivo hamster challenge efficacy study of TATX-03a PolyTope Therapy, for the potential prevention and treatment of SARS-CoV-2.Treatment with TATX-03a substantially reduced bronchit...
Treatment with TATX-03a substantially reduced bronchitis and tracheitis severity in preclinical studies - New histopathology data show that the significantly reduced viral load observed after prophylactic and therapeutic treatment with TATX-03a is accompanied by minimal lung i...
News, Short Squeeze, Breakout and More Instantly...
ImmunoPrecise Antibodies Ltd. Company Name:
IPA Stock Symbol:
NASDAQ Market:
VICTORIA, BC / ACCESSWIRE / April 22, 2024 / ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, has recently announced an expansion of its already successful LENS ai TM Platform. LENS ai , which is run by the company's subsidiary, BioStran...
VICTORIA, BC / ACCESSWIRE/ April 12, 2024 / InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability and speed challenges partnered with ImmunoPrecise Antibodies (NASDAQ:IPA) ("IPA"), an artificial intelligence-dri...
Immunoprecise Antibodies Ltd (NASDAQ:IPA), together with InterSystems, have collaborated to integrate the new vector search capability of the Int...